Home » Topics » BioWorld Science

BioWorld Science
RSS

Idorsia starts phase III REACT study with clazosentan

June 18, 2018

Evotec and Sanofi sign agreement in infectious diseases

June 18, 2018

Aminex initiates phase I study of AMXT-1501 dicaprate in advanced solid tumors

June 18, 2018

Celltrion resubmits aBLA for trastuzumab biosimilar CT-P6

June 18, 2018

Nirogacestat receives U.S. orphan drug designation for desmoid tumors

June 18, 2018

Stemline Therapeutics presents data on SL-401 potentially useful in systemic sclerosis

June 18, 2018

STF-1019 protects against experimental enterovirus 71 infection

June 18, 2018

Phase I/II study of BioAtla's BA-3021 in advanced solid tumors begins

June 18, 2018

CytomX initiates first-in-human study of CX-2029 in patients with solid tumors or DLBCL

June 18, 2018

hVIVO reports results from phase IIb field study of FLU-v

June 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...